Stay updated with breaking news from Patient Support Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Approval based on results from the Phase 3 KEYNOTE-859 trial, which demonstrated significant improvement in overall survival in these patients versus chemotherapy alone Approval marks seventh...
PrJamteki TM is thesecond biosimilar developedunderthispartnershipthatreceivesmarketingauthorization inCanada.
- By inclusion in Ventegra’s formularies, Yuflyma® has secured access through the appropriate channel for about 3.6% of the U.S. populationJERSEY CITY, N.J.--(BUSINESS WIRE)--Celltrion USA has signed a contract with Ventegra ®, a major U.S. Medical Benefits Manager (MBM) who administers pharmacy benefits through its...
Medisafe Joins Forces with AWS to Leverage GenAI and Build the Future ...
The Global Healthy Living Foundation (GHLF), an international U.S.-based non-profit organization committed to improving the lives of people with...